Holista Colltech (ASX:HCT) appointed Leong Man Loong as interim chief executive, effective immediately, according to a Friday filing with the Australian bourse.
Leong is the company's second-largest shareholder. He accepted a nominal salary package of AU$1 for a trial period of six months.
The appointment comes amid headwinds facing the biotech company, including the remaining tranche penalty payment to the Australian Securities and Investments Commission, as per the filing.
The biotech company's shares rose more than 6% in recent Friday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.